OMNIOX, INC.

Profile

Company Names

OMNIOX, INC.

Addresses

181 2ND STREET, SAN FRANCISCO, CA 94105

75 SHOREWAY ROAD, SUITE A, SAN CARLOS, CA 94070

1700 4TH STREET, QB3 BYERS HALL 218C/219 MC2522, SAN FRANCISCO, CA 94158-2330

Phone Numbers

(917) 533-8548
(650) 299-1557
(510) 333-9296

 

Entity Type:

CORPORATION

Industry:

OTHER TECHNOLOGY, BIOTECHNOLOGY

Year Incorporated:

> 5 years ago

State Incorporated:

DELAWARE

Total Amount Raised:

$39,423,963.00

Number of Funding Rounds:

5
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
5
2016-08-01 
$24,066,235.00 
$28,063,773.00 
$3,997,538.00 
Debt 
4
2016-07-12 
$4,708,814.00 
$8,500,000.00 
$3,791,186.00 
Equity, Debt 
3
2014-06-06 
$6,603,710.00 
$6,603,710.00 
$0.00 
Equity 
2
2013-06-17 
$3,043,754.00 
$3,358,754.00 
$315,000.00 
Equity 
1
2012-06-29 
$1,001,450.00 
$7,500,000.00 
$6,498,550.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
STEPHEN 
 
CARY 
EXECUTIVE OFFICER, DIRECTOR
HANDA PHARMACEUTICALS, LLC   |  OMNIOX, INC.
LAURENCE 
 
MARTON 
DIRECTOR
TOMA BIOSCIENCES, INC.   |  TRIDENT LABS, INC.   |  OMNIOX, INC.   |  MATTERNET, INC.
MITCHELL 
 
MUTZ 
DIRECTOR
AMPLYX PHARMACEUTICALS, INC.   |  PURIGEN BIOSYSTEMS, INC.   |  PANDION THERAPEUTICS, INC.   |  GOOD THERAPEUTICS, INC.   |  PANDION THERAPEUTICS HOLDCO LLC   |  BONUM THERAPEUTICS, INC.   |  EPIBIOLOGICS, INC.   |  OMNIOX, INC.
JEFF 
 
SAMBERG 
DIRECTOR
SCHOOL LOOP INC   |  AKONIA HOLOGRAPHICS LLC   |  DEEPDYVE, INC.   |  INTEGRICO COMPOSITES, INC.   |  OMNIOX, INC.   |  TUBE INC   |  SPINE WAVE, INC
JEFFREY 
S. 
SAMBERG 
DIRECTOR
OMNIOX, INC.
AJIT 
 
SHAH 
DIRECTOR
VERAN MEDICAL TECHNOLOGIES, INC.   |  OMNIOX, INC.   |  THERACAINE LLC
JOHN 
 
WESLEY 
DIRECTOR
OMNIOX, INC.   |  DREN BIO, INC.   |  CONNECTICUT SURGERY CENTER, LIMITED PARTNERSHIP
JONATHAN 
 
WINGER 
EXECUTIVE OFFICER, DIRECTOR
OMNIOX, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2026-03-30
D
Link
OTHER TECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2016-08-01 
2016-07-27
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity, Debt 
2016-07-12 
2014-06-18
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2014-06-06 
2013-08-06
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2013-06-17 
2012-07-06
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2012-06-29 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#